{"id":"https://openalex.org/W1509826599","doi":"https://doi.org/10.1016/s0378-5122(01)00245-6","title":"Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy","display_name":"Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy","publication_year":2001,"publication_date":"2001-12-01","ids":{"openalex":"https://openalex.org/W1509826599","doi":"https://doi.org/10.1016/s0378-5122(01)00245-6","mag":"1509826599","pmid":"https://pubmed.ncbi.nlm.nih.gov/11731187"},"language":"en","primary_location":{"id":"doi:10.1016/s0378-5122(01)00245-6","doi":"https://doi.org/10.1016/s0378-5122(01)00245-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5122(01)00245-6","pdf_url":null,"source":{"id":"https://openalex.org/S127492747","display_name":"Maturitas","issn_l":"0378-5122","issn":["0378-5122","1873-4111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Maturitas","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113762864","display_name":"Maurice Antoine Bruhat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Bruhat","raw_affiliation_strings":["Polyclinique H\u00f4tel-Dieu, Clermont-Ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Polyclinique H\u00f4tel-Dieu, Clermont-Ferrand, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110272887","display_name":"Klaus D. Rudolf","orcid":"https://orcid.org/0009-0005-8072-3886","observed_orcids":["https://orcid.org/0009-0005-8072-3886"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Rudolf","raw_affiliation_strings":["FCH Fertility Center Hamburg, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FCH Fertility Center Hamburg, Hamburg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076947637","display_name":"Raija Vaheri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"R Vaheri","raw_affiliation_strings":["Orion Pharma, P.O.B. 65, FIN-02101 Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Pharma, P.O.B. 65, FIN-02101 Espoo, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049960900","display_name":"Petri Kainulainen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"P Kainulainen","raw_affiliation_strings":["Orion Pharma, P.O.B. 65, FIN-02101 Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Pharma, P.O.B. 65, FIN-02101 Espoo, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111789707","display_name":"Ulla Timonen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"U Timonen","raw_affiliation_strings":["Orion Pharma, P.O.B. 65, FIN-02101 Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Pharma, P.O.B. 65, FIN-02101 Espoo, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028090796","display_name":"Antti Viitanen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"A Viitanen","raw_affiliation_strings":["Orion Pharma, P.O.B. 65, FIN-02101 Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Pharma, P.O.B. 65, FIN-02101 Espoo, Finland","institution_ids":["https://openalex.org/I4210118237"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111789707"],"corresponding_institution_ids":["https://openalex.org/I4210118237"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":0.3717,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.61693876,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"40","issue":"3","first_page":"259","last_page":"271"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10694","display_name":"Menopause: Health Impacts and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10694","display_name":"Menopause: Health Impacts and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10600","display_name":"Reproductive Health and Contraception","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/continuous-combined-hormone-replacement-therapy","display_name":"continuous combined hormone replacement therapy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/estradiol-valerate","display_name":"estradiol valerate","score":0.8320000171661377},{"id":"https://openalex.org/keywords/medroxyprogesterone-acetate","display_name":"medroxyprogesterone acetate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/micronized-estradiol","display_name":"micronized estradiol","score":0.972000002861023},{"id":"https://openalex.org/keywords/norethisterone-acetate","display_name":"norethisterone acetate","score":1.0},{"id":"https://openalex.org/keywords/breakthrough-bleeding","display_name":"breakthrough bleeding","score":0.7900000214576721},{"id":"https://openalex.org/keywords/hemorrhage-control","display_name":"hemorrhage control","score":0.6200000047683716},{"id":"https://openalex.org/keywords/menopausal-symptoms","display_name":"menopausal symptoms","score":0.9490000009536743},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.8379999995231628},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.7480000257492065},{"id":"https://openalex.org/keywords/endometrial-safety","display_name":"endometrial safety","score":0.9940000176429749},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9247686266899109},{"id":"https://openalex.org/C2781039349","wikidata":"https://www.wikidata.org/wiki/Q421352","display_name":"Norethisterone","level":4,"score":0.820427417755127},{"id":"https://openalex.org/C2780835420","wikidata":"https://www.wikidata.org/wiki/Q47495694","display_name":"Norethisterone acetate","level":3,"score":0.7904592156410217},{"id":"https://openalex.org/C2776306185","wikidata":"https://www.wikidata.org/wiki/Q2823834","display_name":"Medroxyprogesterone acetate","level":3,"score":0.7521249055862427},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7285736799240112},{"id":"https://openalex.org/C2780159708","wikidata":"https://www.wikidata.org/wiki/Q17003363","display_name":"Hormone replacement therapy (female-to-male)","level":3,"score":0.687731146812439},{"id":"https://openalex.org/C198454886","wikidata":"https://www.wikidata.org/wiki/Q1431745","display_name":"Climacteric","level":3,"score":0.6847428679466248},{"id":"https://openalex.org/C2778001906","wikidata":"https://www.wikidata.org/wiki/Q5401768","display_name":"Estradiol valerate","level":3,"score":0.6172970533370972},{"id":"https://openalex.org/C2777689261","wikidata":"https://www.wikidata.org/wiki/Q686574","display_name":"Endometrial hyperplasia","level":3,"score":0.5876725316047668},{"id":"https://openalex.org/C2778562196","wikidata":"https://www.wikidata.org/wiki/Q177708","display_name":"Menopause","level":2,"score":0.4487707018852234},{"id":"https://openalex.org/C2779742232","wikidata":"https://www.wikidata.org/wiki/Q839508","display_name":"Endometrium","level":2,"score":0.43386223912239075},{"id":"https://openalex.org/C2780275930","wikidata":"https://www.wikidata.org/wiki/Q1628266","display_name":"Hormone therapy","level":4,"score":0.4303009510040283},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4203265309333801},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.3944043517112732},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.38917624950408936},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35740697383880615},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.24916988611221313},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.18041059374809265},{"id":"https://openalex.org/C2986817661","wikidata":"https://www.wikidata.org/wiki/Q185698","display_name":"Research methodology","level":3,"score":0.09609025716781616},{"id":"https://openalex.org/C2779279991","wikidata":"https://www.wikidata.org/wiki/Q6058681","display_name":"Testosterone (patch)","level":2,"score":0.07806757092475891},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.07757601141929626},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077563","descriptor_name":"Norethindrone Acetate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004717","descriptor_name":"Endometrium","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005858","descriptor_name":"Germany","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009640","descriptor_name":"Norethindrone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009640","descriptor_name":"Norethindrone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014592","descriptor_name":"Uterine Hemorrhage","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017258","descriptor_name":"Medroxyprogesterone Acetate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019584","descriptor_name":"Hot Flashes","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D020249","descriptor_name":"Hormone Replacement Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0378-5122(01)00245-6","doi":"https://doi.org/10.1016/s0378-5122(01)00245-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5122(01)00245-6","pdf_url":null,"source":{"id":"https://openalex.org/S127492747","display_name":"Maturitas","issn_l":"0378-5122","issn":["0378-5122","1873-4111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Maturitas","raw_type":"journal-article"},{"id":"pmid:11731187","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11731187","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Maturitas","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1989498280","https://openalex.org/W2005690480","https://openalex.org/W2016631875","https://openalex.org/W2022360622","https://openalex.org/W2022565777","https://openalex.org/W2029180490","https://openalex.org/W2031685386","https://openalex.org/W2034781215","https://openalex.org/W2034832451","https://openalex.org/W2039751703","https://openalex.org/W2039860789","https://openalex.org/W2039904040","https://openalex.org/W2040916868","https://openalex.org/W2058788943","https://openalex.org/W2063717811","https://openalex.org/W2098652499","https://openalex.org/W2126845172","https://openalex.org/W2134262258","https://openalex.org/W2403605878"],"related_works":["https://openalex.org/W2046314567","https://openalex.org/W2063547238","https://openalex.org/W2063717811","https://openalex.org/W1994079641","https://openalex.org/W1992775082","https://openalex.org/W7028609595","https://openalex.org/W1969424919","https://openalex.org/W2058853901","https://openalex.org/W2395871906","https://openalex.org/W4256179242"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}